caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1528088127

Archana SadhuMD

EndocrinologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
580
Unique beneficiaries
—
Total services
4,659
Distinct HCPCS
11
Medicare payment
$142K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 484 Endocrinology providers in TX — top quintile (cohort median 868).
REFERRAL NETWORK

Where Archana Sadhu's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 49 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
66487
Fang Ye
Nurse Practitioner · Houston, TX
43317
Chun Lin
Interventional Cardiology · San Francisco, CA
42156
Tilottama Majumdar
Pulmonary Disease · Birmingham, AL
40122
Nam Yu
Diagnostic Radiology · Los Angeles, CA
3979
Kathryn Sanders
Nurse Practitioner · Houston, TX
38198
HEDRICK, THOMAS3786
John Labis
Diagnostic Radiology · Houston, TX
3582
Rajesh Amin
Diagnostic Radiology · Houston, TX
3470
Su Chang
Cardiology · Houston, TX
3391
Abdul Abdellatif
Nephrology · Webster, TX
31235
Jerry Estep
Cardiology · Houston, TX
29351
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
3,718
Beneficiaries
—
Total drug cost
$1.7M
Distinct drugs
42
Brand share
59.2%
Top prescribed drugs
Semaglutide474 claims
Levothyroxine Sodium298 claims
Atorvastatin Calcium290 claims
Linagliptin248 claims
Empagliflozin235 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$199
Payment records
8
By payment type
Food and Beverage$199